Citation Impact
Citing Papers
A single low dose of cadmium exposure induces benign prostate hyperplasia like condition in rat: A novel benign prostate hyperplasia rodent model
2014
Effects of Tamoxifen and Melatonin on Mammary Gland Cancer Induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, Respectively, in Female Sprague-Dawley Rats
2001
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Endometrial assessment re‐visited
1999
Systematic reviews of evaluations of diagnostic and screening tests
2001 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Does tamoxifen cause cancer in humans?
1998
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
1994
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
1998
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Uterine adenomyosis: a need for uniform terminology and consensus classification
2008
FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age
2011 Standout
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG‐1 ovarian cancer cells
2003
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Mechanisms of Estrogen Action
2001 Standout
Life cycle of connexins in health and disease
2006 Standout
Surgical approach to hysterectomy for benign gynaecological disease
2015 Standout
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout
Works of Dror Yigael being referenced
Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer Patients
1994
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer
1993
Estrogen and Progesterone Receptor Expression in Postmenopausal Tamoxifen-Exposed Endometrial Pathologies
1997
Simple Ovarian Cysts in Postmenopausal Patients with Breast Carcinoma Treated with Tamoxifen: Long-term Follow-up
2003
Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen: A New Entity?
1995